Brazil · Delayed Price · Currency is BRL Bradsaúde Statistics
Total Valuation
Bradsaúde has a market cap or net worth of BRL 45.90 billion. The enterprise value is 46.01 billion.
| Market Cap | 45.90B |
| Enterprise Value | 46.01B |
Important Dates
The last earnings date was Wednesday, October 21, 2026.
| Earnings Date | Oct 21, 2026 |
| Ex-Dividend Date | Nov 3, 2026 |
Share Statistics
Bradsaúde has 2.92 billion shares outstanding. The number of shares has increased by 153.54% in one year.
| Current Share Class | 2.92B |
| Shares Outstanding | 2.92B |
| Shares Change (YoY) | +153.54% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.50% |
| Float | 252.88M |
Valuation Ratios
The trailing PE ratio is 10.33 and the forward PE ratio is 9.24. Bradsaúde's PEG ratio is 0.88.
| PE Ratio | 10.33 |
| Forward PE | 9.24 |
| PS Ratio | 2.00 |
| PB Ratio | 2.33 |
| P/TBV Ratio | 2.57 |
| P/FCF Ratio | 481.77 |
| P/OCF Ratio | 400.65 |
| PEG Ratio | 0.88 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.91, with an EV/FCF ratio of 482.91.
| EV / Earnings | 21.98 |
| EV / Sales | 2.01 |
| EV / EBITDA | 11.91 |
| EV / EBIT | 11.92 |
| EV / FCF | 482.91 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.11 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 2.08 |
| Interest Coverage | 4.65 |
Financial Efficiency
Return on equity (ROE) is 19.98% and return on invested capital (ROIC) is 13.52%.
| Return on Equity (ROE) | 19.98% |
| Return on Assets (ROA) | 10.08% |
| Return on Invested Capital (ROIC) | 13.52% |
| Return on Capital Employed (ROCE) | 13.10% |
| Weighted Average Cost of Capital (WACC) | 8.23% |
| Revenue Per Employee | 11.70M |
| Profits Per Employee | 1.07M |
| Employee Count | 1,957 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 7,733.64 |
Taxes
In the past 12 months, Bradsaúde has paid 840.26 million in taxes.
| Income Tax | 840.26M |
| Effective Tax Rate | 28.65% |
Stock Price Statistics
The stock price has increased by +29.65% in the last 52 weeks. The beta is 0.51, so Bradsaúde's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +29.65% |
| 50-Day Moving Average | 14.76 |
| 200-Day Moving Average | 14.03 |
| Relative Strength Index (RSI) | 57.25 |
| Average Volume (20 Days) | 8,741,105 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bradsaúde had revenue of BRL 22.90 billion and earned 2.09 billion in profits. Earnings per share was 1.52.
| Revenue | 22.90B |
| Gross Profit | 5.71B |
| Operating Income | 3.67B |
| Pretax Income | 2.93B |
| Net Income | 2.09B |
| EBITDA | 3.65B |
| EBIT | 3.67B |
| Earnings Per Share (EPS) | 1.52 |
Balance Sheet
The company has 14.33 billion in cash and 197.87 million in debt, with a net cash position of -106.62 million or -0.04 per share.
| Cash & Cash Equivalents | 14.33B |
| Total Debt | 197.87M |
| Net Cash | -106.62M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | 19.66B |
| Book Value Per Share | 6.72 |
| Working Capital | 1.74B |
Cash Flow
In the last 12 months, operating cash flow was 114.56 million and capital expenditures -19.29 million, giving a free cash flow of 95.27 million.
| Operating Cash Flow | 114.56M |
| Capital Expenditures | -19.29M |
| Depreciation & Amortization | n/a |
| Net Borrowing | -23.66M |
| Free Cash Flow | 95.27M |
| FCF Per Share | 0.03 |
Margins
Gross margin is 24.94%, with operating and profit margins of 16.03% and 9.14%.
| Gross Margin | 24.94% |
| Operating Margin | 16.03% |
| Pretax Margin | 12.80% |
| Profit Margin | 9.14% |
| EBITDA Margin | 15.95% |
| EBIT Margin | 16.03% |
| FCF Margin | 0.42% |
Dividends & Yields
This stock pays an annual dividend of 0.81, which amounts to a dividend yield of 5.18%.
| Dividend Per Share | 0.81 |
| Dividend Yield | 5.18% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 19.74% |
| FCF Payout Ratio | 2,084.26% |
| Buyback Yield | -153.54% |
| Shareholder Yield | -148.36% |
| Earnings Yield | 9.68% |
| FCF Yield | 0.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for Bradsaúde is 18.09, which is 15.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 18.09 |
| Price Target Difference | 15.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 195.03% |
| EPS Growth Forecast (3Y) | 20.93% |
Stock Splits
The last stock split was on April 5, 2022. It was a forward split with a ratio of 1.1.
| Last Split Date | Apr 5, 2022 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |